The DAX in Frankfurt closed about 0.7% firmer at 24,190 on Wednesday, after three consecutive sessions of losses, mirroring a positive mood across European markets. Market sentiment improved on growing expectations of US monetary easing and optimism that tariff impacts on growth will be milder than previously feared. On the domestic data front, Germany’s consumer price inflation remained unchanged at 2% in July, as earlier estimated, aligning with the ECB’s medium-term target. Meanwhile, investor focus is moving toward Friday’s scheduled meeting between US President Donald Trump and Russian President Vladimir Putin. Among key movers, pharma stocks including Bayer (+3.2%), Fresenius SE (+3.2%), and Fresenius Medical Care (+2.9%) posted the biggest gains. Rheinmetall gained 2.2%, tracking a 2.4% rise in RENK after stronger-than-expected order growth. Other notable performers were SAP and Zalando, up 3% and 2.4%, respectively.